Bionano Genomics Inc [NASDAQ: BNGO] loss -35.74% on the last trading session, reaching $1.78 price per share at the time.
Bionano Genomics Inc represents 4.76 million in outstanding shares, while the company has a total market value of $8.46 million with the latest information. BNGO stock price has been found in the range of $1.5 to $1.8.
If compared to the average trading volume of 197.45K shares, BNGO reached a trading volume of 12108321 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Bionano Genomics Inc [BNGO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BNGO shares is $9.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BNGO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Bionano Genomics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 15, 2024. The new note on the price target was released on September 10, 2024, representing the official price target for Bionano Genomics Inc stock. Previously, the target price had yet another raise to $4, while Scotiabank analysts kept a Sector Outperform rating on BNGO stock.
The Price to Book ratio for the last quarter was 0.15, with the Price to Cash per share for the same quarter was set at 5.77.
Trading performance analysis for BNGO stock
Bionano Genomics Inc [BNGO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -59.36. With this latest performance, BNGO shares dropped by -41.45% in over the last four-week period, additionally sinking by -48.70% over the last 6 months – not to mention a drop of -89.71% in the past year of trading.
Bionano Genomics Inc [BNGO]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Bionano Genomics Inc [BNGO] shares currently have an operating margin of -201.16% and a Gross Margin at 5.05%. Bionano Genomics Inc’s Net Margin is presently recorded at -271.02%.
Bionano Genomics Inc (BNGO) Capital Structure & Debt Analysis
According to recent financial data for Bionano Genomics Inc. ( BNGO), the Return on Equity (ROE) stands at -118.26%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -72.39%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Bionano Genomics Inc’s Return on Invested Capital (ROIC) is -144.08%, showcasing its effectiveness in deploying capital for earnings.
Bionano Genomics Inc (BNGO) Efficiency & Liquidity Metrics
Based on Bionano Genomics Inc’s (BNGO) latest financial statements, the Debt-to-Equity Ratio is 0.43%, indicating its reliance on debt financing relative to shareholder equity.
Bionano Genomics Inc (BNGO) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Bionano Genomics Inc. (BNGO) effectively leverages its workforce, generating an average of -$743300.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.76% and a Quick Ratio of 1.41%, indicating strong ability to cover short-term liabilities.
Bionano Genomics Inc [BNGO]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Bionano Genomics Inc posted -16.05/share EPS, while the average EPS was predicted by analysts to be reported at -9.6/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -6.45. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BNGO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bionano Genomics Inc go to 75.99%.
An analysis of Institutional ownership at Bionano Genomics Inc [BNGO]
There are presently around $2.15%, or 2.15%% of BNGO stock, in the hands of institutional investors. The top three institutional holders of BNGO stocks are: VANGUARD GROUP INC with ownership of 2.09 million shares, which is approximately 1.293%. ARMISTICE CAPITAL, LLC, holding 1.68 million shares of the stock with an approximate value of $$1.14 million in BNGO stocks shares; and ARMISTICE CAPITAL, LLC, currently with $$0.41 million in BNGO stock with ownership which is approximately 0.3759%.
